GEMCITABINE HYDROCHLORIDE

GEMCITABINE HYDROCHLORIDE was reported 30166 times

GEMCITABINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOCELLULITIS 62 0.7848
1 DESMOPLASTIC SMALL ROUND CELL TUMOUR 20 0.3571
2 PSEUDOCIRRHOSIS 64 0.3351
3 REFRACTORY CANCER 37 0.2606
4 PIK3CA-ACTIVATED MUTATION 36 0.2466
5 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 72 0.2105
6 BILIARY TRACT INFECTION 84 0.2100
7 HORMONE RECEPTOR POSITIVE BREAST CANCER 14 0.1972
8 TOXIC ERYTHEMA OF CHEMOTHERAPY 19 0.1810
9 RECALL PHENOMENON 113 0.1766
10 LYMPHANGIOLEIOMYOMATOSIS 14 0.1667
11 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 145 0.1551
12 METASTASES TO RETROPERITONEUM 17 0.1491
13 SCLERODERMA-LIKE REACTION 13 0.1477
14 BILIARY SEPSIS 48 0.1375
15 PANCREATIC FISTULA 14 0.1346
16 METASTASES TO MUSCLE 15 0.1304
17 CHOLANGITIS INFECTIVE 14 0.1094
18 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 37 0.1085
19 HAEMOLYTIC URAEMIC SYNDROME 213 0.1082
20 PANCREATIC CARCINOMA METASTATIC 232 0.1012
21 METASTASES TO BONE MARROW 32 0.0961
22 DUODENITIS HAEMORRHAGIC 12 0.0916
23 THROMBOTIC MICROANGIOPATHY 536 0.0909
24 METASTASES TO SPLEEN 26 0.0850
25 CAPILLARY LEAK SYNDROME 108 0.0833
26 RENAL SALT-WASTING SYNDROME 14 0.0795
27 ADENOCARCINOMA PANCREAS 81 0.0777
28 CHOLANGITIS 301 0.0774
29 POST THROMBOTIC SYNDROME 30 0.0759
30 OVARIAN CANCER RECURRENT 46 0.0759
31 METASTASES TO SKIN 46 0.0693
32 METASTASES TO PERITONEUM 103 0.0665
33 BONE MARROW INFILTRATION 14 0.0622
34 CARBOHYDRATE ANTIGEN 19-9 INCREASED 20 0.0619
35 BILE DUCT STENOSIS 54 0.0616
36 AORTIC THROMBOSIS 49 0.0611
37 IMMUNE-MEDIATED HEPATITIS 33 0.0608
38 DUODENAL STENOSIS 21 0.0602
39 HAEMATOTOXICITY 321 0.0601
40 GASTROINTESTINAL TOXICITY 155 0.0593
41 GASTROENTERITIS RADIATION 15 0.0584
42 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 31 0.0573
43 DUODENAL OBSTRUCTION 12 0.0556
44 FISTULA OF SMALL INTESTINE 12 0.0545
45 EGFR GENE MUTATION 12 0.0511
46 METASTASES TO THE MEDIASTINUM 15 0.0508
47 BILIARY OBSTRUCTION 14 0.0505
48 LEIOMYOSARCOMA 14 0.0479
49 ECZEMA ASTEATOTIC 14 0.0478
50 NEUTROPENIC SEPSIS 251 0.0473
51 OBSTRUCTION GASTRIC 39 0.0458
52 CHOLANGITIS ACUTE 21 0.0443
53 METASTASES TO PLEURA 27 0.0443
54 ACQUIRED DIAPHRAGMATIC EVENTRATION 12 0.0441
55 ENTEROCOLITIS INFECTIOUS 31 0.0437
56 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 50 0.0427
57 DISSEMINATED CRYPTOCOCCOSIS 15 0.0420
58 METASTASES TO PELVIS 15 0.0420
59 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 16 0.0406
60 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 31 0.0396
61 STENT OCCLUSION 21 0.0395
62 MYELOSUPPRESSION 165 0.0393
63 BLADDER CANCER RECURRENT 27 0.0381
64 MALIGNANT ASCITES 21 0.0380
65 CHOLANGIOCARCINOMA 33 0.0379
66 HYPERTRANSAMINASAEMIA 89 0.0379
67 NECROSIS ISCHAEMIC 13 0.0367
68 THERAPY PARTIAL RESPONDER 124 0.0357
69 BONE MARROW TOXICITY 43 0.0354
70 METASTASES TO LUNG 264 0.0354
71 METASTASES TO ABDOMINAL CAVITY 12 0.0353
72 METASTASES TO ADRENALS 22 0.0351
73 MUSCLE NECROSIS 22 0.0337
74 BILE DUCT OBSTRUCTION 64 0.0334
75 METASTASES TO LIVER 385 0.0329
76 LIVER ABSCESS 71 0.0327
77 METASTASES TO LYMPH NODES 137 0.0325
78 NEUTROPENIC INFECTION 24 0.0323
79 TUMOUR NECROSIS 24 0.0317
80 PULMONARY TOXICITY 119 0.0312
81 THROMBOTIC THROMBOCYTOPENIC PURPURA 91 0.0311
82 VENA CAVA THROMBOSIS 40 0.0309
83 TRANSITIONAL CELL CARCINOMA 25 0.0305
84 TRACHEO-OESOPHAGEAL FISTULA 15 0.0302
85 PERITONEAL DISORDER 15 0.0298
86 B-CELL LYMPHOMA RECURRENT 12 0.0297
87 THROMBOCYTOPENIA 2269 0.0297
88 THROMBOCYTOSIS 71 0.0297
89 PERIPHERAL ISCHAEMIA 89 0.0290
90 CHOROIDAL EFFUSION 14 0.0290
91 PANCREATIC MASS 21 0.0288
92 MYCOSIS FUNGOIDES 24 0.0287
93 MYOSITIS 164 0.0281
94 LYMPHANGIOSIS CARCINOMATOSA 21 0.0279
95 CYTOPENIA 142 0.0277
96 LYMPHANGITIS 17 0.0277
97 PERIPHERAL SENSORY NEUROPATHY 107 0.0276
98 ACQUIRED GENE MUTATION 22 0.0271
99 FEBRILE NEUTROPENIA 1129 0.0268
100 OVARIAN CANCER METASTATIC 16 0.0263
101 PULMONARY ARTERY THROMBOSIS 15 0.0263
102 ALVEOLITIS 32 0.0260
103 EXTREMITY NECROSIS 33 0.0259
104 NEOPLASM RECURRENCE 60 0.0259
105 NEUTROPENIA 2079 0.0258
106 DIFFUSE LARGE B-CELL LYMPHOMA 102 0.0257
107 DISEASE PROGRESSION 1799 0.0255
108 SKIN TOXICITY 79 0.0252
109 MALIGNANT NEOPLASM PROGRESSION 1586 0.0250
110 PERFORMANCE STATUS DECREASED 87 0.0246
111 NON-SMALL CELL LUNG CANCER 58 0.0245
112 HEPATIC INFECTION 19 0.0243
113 GRANULOCYTE COUNT DECREASED 17 0.0242
114 COMPUTERISED TOMOGRAM THORAX ABNORMAL 14 0.0242
115 HYPOALBUMINAEMIA 123 0.0241
116 EMBOLISM 151 0.0240
117 BONE MARROW FAILURE 425 0.0237
118 OTOTOXICITY 30 0.0234
119 NEUROTOXICITY 241 0.0229
120 NEOPLASM PROGRESSION 504 0.0228
121 CAUDA EQUINA SYNDROME 12 0.0227
122 METASTASES TO MENINGES 29 0.0225
123 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 136 0.0224
124 PORTAL HYPERTENSION 49 0.0224
125 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 12 0.0223
126 EMBOLISM ARTERIAL 20 0.0221
127 CYTOKINE RELEASE SYNDROME 102 0.0221
128 METASTASES TO BONE 216 0.0218
129 PERIPHERAL ARTERY THROMBOSIS 21 0.0218
130 NEUTROPHIL COUNT ABNORMAL 39 0.0217
131 SECOND PRIMARY MALIGNANCY 125 0.0216
132 ESCHERICHIA BACTERAEMIA 29 0.0214
133 SYSTOLIC DYSFUNCTION 15 0.0212
134 METASTASES TO CENTRAL NERVOUS SYSTEM 167 0.0210
135 BICYTOPENIA 21 0.0209
136 MUCOSAL INFLAMMATION 378 0.0208
137 MALIGNANT HYPERTENSION 15 0.0208
138 CATHETER RELATED INFECTION 21 0.0207
139 ALLERGY TO CHEMICALS 15 0.0207
140 PNEUMONITIS 343 0.0205
141 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0204
142 BREAST CANCER METASTATIC 151 0.0204
143 LEUKOPENIA 711 0.0203
144 TUMOUR PAIN 18 0.0198
145 SPLENIC INFARCTION 25 0.0195
146 EMBOLISM VENOUS 41 0.0193
147 TUMOUR LYSIS SYNDROME 103 0.0192
148 PERIPHERAL MOTOR NEUROPATHY 19 0.0189
149 CYSTOID MACULAR OEDEMA 22 0.0189
150 ENTEROCUTANEOUS FISTULA 12 0.0189
151 BILE DUCT CANCER 17 0.0188
152 CARDIOTOXICITY 93 0.0188
153 JAUNDICE CHOLESTATIC 50 0.0187
154 ENTERITIS 74 0.0187
155 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 298 0.0187
156 RECURRENT CANCER 43 0.0186
157 ACUTE MYELOID LEUKAEMIA 199 0.0186
158 ASCITES 392 0.0185
159 DERMATITIS ACNEIFORM 73 0.0181
160 MESENTERIC VEIN THROMBOSIS 13 0.0181
161 FEBRILE INFECTION 13 0.0181
162 METASTASES TO SPINE 39 0.0181
163 BREAST CANCER RECURRENT 39 0.0180
164 HYPERAMMONAEMIC ENCEPHALOPATHY 22 0.0178
165 NEPHROPATHY TOXIC 124 0.0178
166 ADENOCARCINOMA 29 0.0177
167 PANCYTOPENIA 673 0.0175
168 ABDOMINAL INFECTION 29 0.0174
169 HYPERPYREXIA 41 0.0174
170 PORTAL VEIN THROMBOSIS 40 0.0173
171 URINARY TRACT OBSTRUCTION 29 0.0173
172 BILIARY DILATATION 19 0.0172
173 BACTERAEMIA 129 0.0172
174 PNEUMOCYSTIS JIROVECII PNEUMONIA 99 0.0170
175 SUBCLAVIAN VEIN THROMBOSIS 16 0.0169
176 MENINGITIS CRYPTOCOCCAL 18 0.0168
177 METASTATIC NEOPLASM 49 0.0168
178 CYTOMEGALOVIRUS CHORIORETINITIS 21 0.0166
179 FAILURE TO THRIVE 68 0.0165
180 NEUTROPHIL COUNT DECREASED 404 0.0164
181 ENTEROCOLITIS 55 0.0163
182 CEREBRAL ISCHAEMIA 70 0.0163
183 RADIATION SKIN INJURY 15 0.0163
184 SARCOMA 13 0.0160
185 GASTROINTESTINAL PERFORATION 47 0.0159
186 LIVEDO RETICULARIS 24 0.0158
187 POLYNEUROPATHY 116 0.0156
188 LYMPHOEDEMA 70 0.0156
189 URETERIC OBSTRUCTION 16 0.0154
190 SYSTEMIC CANDIDA 22 0.0154
191 METASTASIS 72 0.0154
192 LEFT VENTRICULAR DYSFUNCTION 73 0.0154
193 RENAL INFARCT 16 0.0153
194 DYSAESTHESIA 33 0.0151
195 GASTRIC PERFORATION 27 0.0150
196 LUNG ADENOCARCINOMA 31 0.0149
197 SUBILEUS 25 0.0149
198 COMPUTERISED TOMOGRAM ABNORMAL 27 0.0148
199 VENOUS THROMBOSIS 45 0.0147
200 INVASIVE DUCTAL BREAST CARCINOMA 27 0.0147
201 DISEASE RECURRENCE 240 0.0146
202 BILIARY TRACT DISORDER 15 0.0146
203 SMALL INTESTINAL OBSTRUCTION 126 0.0145
204 ALVEOLITIS ALLERGIC 15 0.0145
205 CARDIAC DEATH 14 0.0143
206 NEUTROPENIC COLITIS 16 0.0142
207 MALIGNANT PLEURAL EFFUSION 17 0.0141
208 HYPOPHOSPHATAEMIA 67 0.0141
209 ANAEMIA 1950 0.0141
210 LYMPHADENOPATHY MEDIASTINAL 18 0.0140
211 DIFFUSE ALVEOLAR DAMAGE 12 0.0138
212 SMALL INTESTINAL PERFORATION 17 0.0137
213 PLEURAL EFFUSION 613 0.0136
214 LARYNGOSPASM 29 0.0136
215 DIABETIC METABOLIC DECOMPENSATION 12 0.0134
216 THROMBOPHLEBITIS 38 0.0134
217 HYPERBILIRUBINAEMIA 95 0.0134
218 GASTROINTESTINAL ULCER 23 0.0133
219 DRUG RESISTANCE 217 0.0133
220 ESCHERICHIA SEPSIS 28 0.0132
221 UROSEPSIS 83 0.0130
222 GENE MUTATION 15 0.0129
223 OESOPHAGEAL VARICES HAEMORRHAGE 21 0.0128
224 SMALL INTESTINAL HAEMORRHAGE 20 0.0128
225 HEPATOTOXICITY 184 0.0128
226 HEPATORENAL SYNDROME 17 0.0126
227 OSTEOSCLEROSIS 15 0.0124
228 NEUROPATHY PERIPHERAL 746 0.0124
229 JC VIRUS INFECTION 12 0.0123
230 ARTERIAL THROMBOSIS 19 0.0123
231 ORGANISING PNEUMONIA 36 0.0122
232 PANCREATIC CARCINOMA 244 0.0122
233 TRANSAMINASES INCREASED 197 0.0121
234 AUTOIMMUNE HAEMOLYTIC ANAEMIA 24 0.0120
235 MULTIPLE-DRUG RESISTANCE 17 0.0119
236 URINARY TRACT INFECTION BACTERIAL 19 0.0118
237 JUGULAR VEIN THROMBOSIS 15 0.0118
238 ACUTE LYMPHOCYTIC LEUKAEMIA 24 0.0118
239 EMPYEMA 16 0.0118
240 FEBRILE BONE MARROW APLASIA 33 0.0118
241 STRESS CARDIOMYOPATHY 41 0.0117
242 ABDOMINAL MASS 21 0.0117
243 TROPONIN INCREASED 53 0.0117
244 LEFT VENTRICULAR FAILURE 29 0.0116
245 LARGE INTESTINAL OBSTRUCTION 16 0.0113
246 PERICARDIAL EFFUSION 176 0.0112
247 ORAL INTAKE REDUCED 27 0.0112
248 LUNG CONSOLIDATION 23 0.0112
249 HYPOMAGNESAEMIA 98 0.0111
250 INTERSTITIAL LUNG DISEASE 355 0.0111
251 ATELECTASIS 83 0.0110
252 KLEBSIELLA INFECTION 35 0.0109
253 HYDRONEPHROSIS 58 0.0109
254 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32 0.0109
255 PROTEINURIA 131 0.0109
256 HEPATOCELLULAR INJURY 133 0.0109
257 CULTURE URINE POSITIVE 13 0.0108
258 QUADRIPLEGIA 17 0.0108
259 PARONYCHIA 30 0.0108
260 LYMPHOPENIA 98 0.0106
261 CATHETER RELATED COMPLICATION 12 0.0106
262 LUNG INFILTRATION 80 0.0106
263 RADIATION PNEUMONITIS 15 0.0105
264 HAEMOLYTIC ANAEMIA 72 0.0105
265 CACHEXIA 39 0.0104
266 PULMONARY ALVEOLAR HAEMORRHAGE 37 0.0104
267 SEPSIS 826 0.0103
268 TUMOUR MARKER INCREASED 29 0.0103
269 AZOTAEMIA 29 0.0102
270 GENERALISED OEDEMA 86 0.0102
271 BLOOD CULTURE POSITIVE 27 0.0102
272 ERYSIPELAS 37 0.0101
273 PSYCHOMOTOR SKILLS IMPAIRED 19 0.0101
274 BLOOD ALBUMIN DECREASED 60 0.0101
275 ILEUS 87 0.0100
276 SKIN NECROSIS 40 0.0100
277 MYELODYSPLASTIC SYNDROME 107 0.0099
278 METABOLIC DISORDER 43 0.0099
279 PLATELET COUNT DECREASED 710 0.0099
280 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0099
281 BONE MARROW DISORDER 20 0.0099
282 GENERAL PHYSICAL HEALTH DETERIORATION 691 0.0098
283 VOCAL CORD PARALYSIS 13 0.0098
284 ILEUS PARALYTIC 31 0.0098
285 PULMONARY EMBOLISM 729 0.0097
286 HEPATIC MASS 12 0.0097
287 DEVICE OCCLUSION 60 0.0096
288 PNEUMOTHORAX 104 0.0096
289 SEPTIC SHOCK 277 0.0096
290 PANNICULITIS 15 0.0095
291 GRAFT VERSUS HOST DISEASE 52 0.0095
292 CHOLESTASIS 125 0.0095
293 ACUTE PULMONARY OEDEMA 41 0.0095
294 LARGE INTESTINE PERFORATION 48 0.0094
295 AMYLASE INCREASED 23 0.0093
296 WHITE BLOOD CELL DISORDER 17 0.0093
297 ARTERIOSPASM CORONARY 24 0.0092
298 DUODENITIS 21 0.0092
299 DUODENAL ULCER 48 0.0091
300 BONE LESION 23 0.0091
301 CANCER PAIN 14 0.0091
302 HAEMOLYSIS 52 0.0090
303 DEEP VEIN THROMBOSIS 483 0.0090
304 COLITIS 208 0.0090
305 BACTERIAL SEPSIS 21 0.0090
306 ENTEROCOCCAL INFECTION 29 0.0090
307 BREAST DISORDER 13 0.0088
308 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0088
309 BLOOD ALKALINE PHOSPHATASE INCREASED 176 0.0088
310 BLOOD BILIRUBIN INCREASED 183 0.0088
311 ISCHAEMIA 32 0.0087
312 HEPATIC LESION 25 0.0086
313 INTESTINAL PERFORATION 69 0.0086
314 VENOUS THROMBOSIS LIMB 14 0.0085
315 TACHYARRHYTHMIA 17 0.0084
316 BLOOD DISORDER 48 0.0084
317 HYPERCALCAEMIA 73 0.0084
318 PLEURISY 40 0.0084
319 HEPATITIS B REACTIVATION 16 0.0083
320 CARDIAC FAILURE ACUTE 35 0.0083
321 SKIN MASS 35 0.0083
322 CYSTITIS HAEMORRHAGIC 23 0.0083
323 RETINOPATHY 23 0.0083
324 CARDIOMYOPATHY 92 0.0082
325 HEPATIC NEOPLASM 20 0.0082
326 OSTEOLYSIS 12 0.0082
327 ATYPICAL PNEUMONIA 15 0.0082
328 LUNG CANCER METASTATIC 18 0.0082
329 HAEMOGLOBIN ABNORMAL 33 0.0082
330 HYPOXIA 194 0.0081
331 DISSEMINATED INTRAVASCULAR COAGULATION 89 0.0080
332 SPINAL CORD COMPRESSION 23 0.0080
333 HYPOCALCAEMIA 105 0.0080
334 CARBOHYDRATE ANTIGEN 125 INCREASED 19 0.0080
335 STAPHYLOCOCCAL BACTERAEMIA 22 0.0080
336 ACUTE RESPIRATORY DISTRESS SYNDROME 100 0.0079
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 119 0.0079
338 HEPATIC FAILURE 181 0.0079
339 NORMOCHROMIC NORMOCYTIC ANAEMIA 18 0.0079
340 THROMBOPHLEBITIS SUPERFICIAL 24 0.0078
341 BLOOD LACTATE DEHYDROGENASE INCREASED 99 0.0078
342 VENOOCCLUSIVE LIVER DISEASE 25 0.0077
343 JAUNDICE 166 0.0077
344 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0076
345 CLOSTRIDIUM DIFFICILE COLITIS 57 0.0076
346 PHLEBITIS 31 0.0076
347 LEUKOCYTOSIS 98 0.0076
348 DEVICE RELATED INFECTION 91 0.0076
349 LOBAR PNEUMONIA 14 0.0075
350 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0075
351 HYPOVOLAEMIA 33 0.0075
352 VENTRICULAR HYPOKINESIA 18 0.0075
353 CHOLECYSTITIS 65 0.0075
354 CHANGE OF BOWEL HABIT 12 0.0075
355 BLOOD CHLORIDE DECREASED 16 0.0075
356 VARICES OESOPHAGEAL 16 0.0074
357 BACTERIAL TEST POSITIVE 12 0.0074
358 LEUKOCYTOCLASTIC VASCULITIS 12 0.0074
359 CHRONIC LYMPHOCYTIC LEUKAEMIA 23 0.0073
360 ATRIAL FLUTTER 45 0.0073
361 DEHYDRATION 722 0.0073
362 SUPRAVENTRICULAR TACHYCARDIA 53 0.0073
363 NEPHROTIC SYNDROME 35 0.0073
364 CARDIOPULMONARY FAILURE 23 0.0073
365 PLEURITIC PAIN 16 0.0073
366 GASTROINTESTINAL OBSTRUCTION 12 0.0072
367 TUMOUR HAEMORRHAGE 14 0.0072
368 HYPOKALAEMIA 230 0.0072
369 COMPARTMENT SYNDROME 14 0.0072
370 AREFLEXIA 15 0.0072
371 NEUTROPHIL COUNT INCREASED 54 0.0071
372 LIPASE INCREASED 41 0.0071
373 ASPARTATE AMINOTRANSFERASE INCREASED 285 0.0071
374 PYREXIA 1725 0.0071
375 HICCUPS 40 0.0070
376 CARDIAC TAMPONADE 24 0.0070
377 HAEMATOCRIT DECREASED 111 0.0070
378 OVARIAN CANCER 47 0.0070
379 EXPOSED BONE IN JAW 14 0.0070
380 APLASIA 12 0.0070
381 NECROSIS 30 0.0070
382 ESCHERICHIA INFECTION 37 0.0070
383 LUNG INFECTION 109 0.0069
384 PNEUMONIA VIRAL 14 0.0069
385 IMMUNE THROMBOCYTOPENIC PURPURA 20 0.0069
386 GUILLAIN-BARRE SYNDROME 22 0.0069
387 SCLERODERMA 19 0.0069
388 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0068
389 RENAL TUBULAR NECROSIS 48 0.0068
390 BRONCHOPULMONARY ASPERGILLOSIS 33 0.0068
391 ALANINE AMINOTRANSFERASE INCREASED 314 0.0068
392 HAEMOGLOBIN DECREASED 506 0.0067
393 SINUS TACHYCARDIA 71 0.0067
394 RESPIRATORY FAILURE 365 0.0067
395 HAEMOPTYSIS 141 0.0067
396 SKIN INFECTION 48 0.0067
397 EJECTION FRACTION DECREASED 71 0.0067
398 UPPER GASTROINTESTINAL HAEMORRHAGE 87 0.0066
399 HYPONATRAEMIA 270 0.0066
400 WOUND DEHISCENCE 17 0.0065
401 LYMPHOCYTE COUNT DECREASED 79 0.0065
402 RASH MACULO-PAPULAR 98 0.0065
403 PATHOLOGICAL FRACTURE 24 0.0065
404 LOCALISED OEDEMA 23 0.0065
405 STAPHYLOCOCCAL SEPSIS 25 0.0065
406 OESOPHAGEAL STENOSIS 13 0.0065
407 ELECTROLYTE IMBALANCE 50 0.0065
408 ORAL CANDIDIASIS 56 0.0064
409 HEPATITIS B 30 0.0064
410 PLATELET COUNT ABNORMAL 24 0.0064
411 HEPATITIS CHOLESTATIC 27 0.0063
412 MALNUTRITION 47 0.0062
413 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44 0.0062
414 THERAPY NON-RESPONDER 136 0.0061
415 DIVERTICULUM INTESTINAL 19 0.0061
416 WHITE BLOOD CELL COUNT DECREASED 439 0.0061
417 HEPATIC FUNCTION ABNORMAL 147 0.0061
418 PULMONARY MASS 59 0.0061
419 B-CELL LYMPHOMA 16 0.0060
420 ACUTE CORONARY SYNDROME 40 0.0060
421 OESOPHAGITIS 48 0.0060
422 BLOOD MAGNESIUM DECREASED 34 0.0060
423 HYPERTENSIVE CRISIS 49 0.0060
424 DYSPNOEA EXERTIONAL 145 0.0060
425 PNEUMONIA BACTERIAL 29 0.0059
426 ACUTE KIDNEY INJURY 580 0.0059
427 DUODENAL ULCER HAEMORRHAGE 14 0.0059
428 AGRANULOCYTOSIS 69 0.0059
429 HYPERAMMONAEMIA 20 0.0059
430 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0059
431 NON-CARDIAC CHEST PAIN 16 0.0059
432 CLOSTRIDIAL INFECTION 18 0.0059
433 HYPOPHAGIA 101 0.0058
434 FLANK PAIN 39 0.0058
435 LYMPHADENOPATHY 144 0.0058
436 CELLULITIS 215 0.0058
437 ABDOMINAL PAIN 938 0.0057
438 PROTEIN TOTAL DECREASED 16 0.0057
439 RENAL FAILURE CHRONIC 44 0.0057
440 TREATMENT FAILURE 290 0.0057
441 STOMATITIS 225 0.0057
442 RENAL FAILURE ACUTE 240 0.0056
443 PULMONARY FIBROSIS 68 0.0056
444 OEDEMA PERIPHERAL 534 0.0055
445 HEPATITIS ACUTE 26 0.0055
446 WHITE BLOOD CELL COUNT ABNORMAL 22 0.0054
447 OEDEMA 202 0.0053
448 PLATELET COUNT INCREASED 47 0.0053
449 PRESYNCOPE 90 0.0053
450 PURPURA 36 0.0053
451 WOUND HAEMORRHAGE 14 0.0053
452 DERMATITIS 69 0.0053
453 VASCULITIS 41 0.0052
454 HEPATIC PAIN 16 0.0052
455 PYELONEPHRITIS 31 0.0052
456 WOUND SECRETION 16 0.0052
457 BLOOD CREATININE INCREASED 251 0.0052
458 ORTHOPNOEA 13 0.0051
459 HYPERURICAEMIA 15 0.0051
460 PROTHROMBIN TIME PROLONGED 27 0.0051
461 INFECTION 469 0.0051
462 ACIDOSIS 29 0.0050
463 HYPERGLYCAEMIA 135 0.0050
464 BLOOD SODIUM DECREASED 67 0.0050
465 LUNG DISORDER 165 0.0050
466 HYPERTHERMIA 28 0.0049
467 BACTERIAL INFECTION 59 0.0049
468 MENTAL STATUS CHANGES 104 0.0049
469 HYPERSENSITIVITY VASCULITIS 12 0.0048
470 MYOCARDIAL ISCHAEMIA 47 0.0048
471 ESCHERICHIA URINARY TRACT INFECTION 15 0.0048
472 ENCEPHALOPATHY 81 0.0048
473 PULMONARY TUBERCULOSIS 16 0.0048
474 TOXIC SKIN ERUPTION 35 0.0048
475 IMPAIRED GASTRIC EMPTYING 25 0.0048
476 ASPERGILLUS INFECTION 17 0.0048
477 RALES 20 0.0048
478 ABDOMINAL TENDERNESS 18 0.0048
479 HAEMORRHAGIC DIATHESIS 13 0.0048
480 ANGIOPATHY 21 0.0048
481 C-REACTIVE PROTEIN INCREASED 111 0.0048
482 INTESTINAL ISCHAEMIA 19 0.0048
483 BREATH SOUNDS ABNORMAL 15 0.0047
484 LOOSE TOOTH 12 0.0047
485 ANOREXIA 61 0.0047
486 EPISTAXIS 260 0.0047
487 VOMITING 1546 0.0047
488 OSTEONECROSIS OF JAW 96 0.0047
489 HAEMATURIA 125 0.0047
490 INTESTINAL OBSTRUCTION 115 0.0047
491 GENERALISED TONIC-CLONIC SEIZURE 48 0.0047
492 HAEMATEMESIS 90 0.0047
493 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 19 0.0046
494 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 12 0.0046
495 ACUTE MYOCARDIAL INFARCTION 108 0.0046
496 CARDIAC FAILURE 258 0.0046
497 BLOOD CREATINE INCREASED 14 0.0045
498 RETINAL HAEMORRHAGE 24 0.0045
499 PULSE ABSENT 17 0.0045
500 ACUTE RESPIRATORY FAILURE 55 0.0045
501 CONGESTIVE CARDIOMYOPATHY 17 0.0045
502 LUNG NEOPLASM 16 0.0045
503 HEPATITIS 82 0.0045
504 INTRACARDIAC THROMBUS 12 0.0045
505 BLOOD LACTIC ACID INCREASED 15 0.0044
506 PRODUCT USE IN UNAPPROVED INDICATION 527 0.0044
507 ISCHAEMIC STROKE 60 0.0044
508 TUBULOINTERSTITIAL NEPHRITIS 57 0.0044
509 HYPOVOLAEMIC SHOCK 15 0.0044
510 TOXICITY TO VARIOUS AGENTS 485 0.0043
511 BODY TEMPERATURE INCREASED 66 0.0043
512 LYMPHOMA 47 0.0043
513 CEREBRAL INFARCTION 80 0.0043
514 HEPATIC STEATOSIS 57 0.0043
515 COLITIS ISCHAEMIC 21 0.0043
516 PULMONARY OEDEMA 140 0.0043
517 PAPILLOEDEMA 14 0.0043
518 DECREASED APPETITE 652 0.0043
519 DRUG TOXICITY 58 0.0043
520 PNEUMONIA ASPIRATION 74 0.0042
521 GASTRITIS 82 0.0042
522 LEUKOENCEPHALOPATHY 12 0.0042
523 CANDIDIASIS 17 0.0042
524 DECUBITUS ULCER 26 0.0042
525 PNEUMONIA 926 0.0042
526 REFUSAL OF TREATMENT BY PATIENT 21 0.0042
527 SENSORY LOSS 25 0.0042
528 CHILLS 345 0.0042
529 AORTIC DISSECTION 14 0.0041
530 HEPATIC ENCEPHALOPATHY 29 0.0041
531 LIVER INJURY 49 0.0041
532 CANDIDA INFECTION 42 0.0041
533 DRUG INTOLERANCE 247 0.0041
534 WHITE BLOOD CELL COUNT INCREASED 119 0.0041
535 LIVER FUNCTION TEST ABNORMAL 101 0.0041
536 DRUG-INDUCED LIVER INJURY 64 0.0040
537 MUSCULOSKELETAL CHEST PAIN 44 0.0040
538 TRICUSPID VALVE INCOMPETENCE 23 0.0040
539 SUDDEN DEATH 35 0.0040
540 ODYNOPHAGIA 16 0.0040
541 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 12 0.0040
542 LIVER FUNCTION TEST INCREASED 48 0.0040
543 PURULENT DISCHARGE 13 0.0040
544 CHOLECYSTITIS ACUTE 17 0.0040
545 DERMATITIS EXFOLIATIVE 18 0.0040
546 MYOPATHY 25 0.0040
547 PETECHIAE 30 0.0039
548 NEOPLASM 29 0.0039
549 PULMONARY HAEMORRHAGE 24 0.0039
550 RESPIRATORY TRACT INFECTION 65 0.0039
551 RED BLOOD CELL COUNT DECREASED 75 0.0039
552 TACHYCARDIA 245 0.0039
553 ASTHENIA 1025 0.0039
554 NEUTROPHILIA 12 0.0038
555 RENAL IMPAIRMENT 212 0.0038
556 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0038
557 ACUTE HEPATIC FAILURE 34 0.0038
558 SPLENOMEGALY 32 0.0038
559 ORGAN FAILURE 12 0.0037
560 SKIN REACTION 37 0.0037
561 INFUSION SITE PAIN 25 0.0037
562 CONSTIPATION 522 0.0037
563 MELAENA 62 0.0037
564 GASTRIC ULCER 54 0.0037
565 ABSCESS 40 0.0037
566 PSEUDOMONAS INFECTION 20 0.0037
567 GRANULOCYTOPENIA 18 0.0037
568 EXTRAVASATION 12 0.0036
569 BLOOD UREA INCREASED 50 0.0036
570 RENAL FAILURE 389 0.0036
571 OLIGURIA 17 0.0036
572 ORAL DISORDER 19 0.0036
573 ATRIAL FIBRILLATION 245 0.0036
574 GASTROINTESTINAL HAEMORRHAGE 249 0.0036
575 PAPULE 14 0.0035
576 ANAPHYLACTIC REACTION 124 0.0035
577 CARDIOMEGALY 36 0.0035
578 PERONEAL NERVE PALSY 15 0.0035
579 MASS 36 0.0035
580 LIVER DISORDER 105 0.0035
581 ADRENAL INSUFFICIENCY 22 0.0034
582 RESPIRATORY DISTRESS 71 0.0034
583 CONJUNCTIVITIS 36 0.0034
584 HYPERKALAEMIA 84 0.0033
585 OFF LABEL USE 1456 0.0033
586 ANURIA 23 0.0033
587 GASTRIC HAEMORRHAGE 31 0.0033
588 NAUSEA 1842 0.0033
589 DIARRHOEA 1409 0.0033
590 MOTOR DYSFUNCTION 24 0.0033
591 MOUTH HAEMORRHAGE 17 0.0033
592 GINGIVITIS 13 0.0033
593 GANGRENE 16 0.0033
594 INTRACRANIAL PRESSURE INCREASED 13 0.0033
595 DERMATITIS BULLOUS 17 0.0033
596 URINARY RETENTION 77 0.0033
597 CIRCULATORY COLLAPSE 44 0.0032
598 HYPOTENSION 460 0.0032
599 SKIN PLAQUE 17 0.0032
600 PERITONITIS BACTERIAL 26 0.0032
601 ORTHOSTATIC HYPOTENSION 40 0.0032
602 NAIL DISORDER 17 0.0032
603 PERIORBITAL OEDEMA 12 0.0032
604 SKIN ULCER 59 0.0032
605 BLOOD PRESSURE DIASTOLIC DECREASED 15 0.0032
606 GASTROENTERITIS 33 0.0031
607 HAEMODYNAMIC INSTABILITY 15 0.0031
608 HYPOKINESIA 33 0.0031
609 EPSTEIN-BARR VIRUS INFECTION 13 0.0031
610 GASTROINTESTINAL INFECTION 18 0.0031
611 SYNCOPE 226 0.0031
612 URINE OUTPUT DECREASED 21 0.0031
613 AUTOIMMUNE HEPATITIS 14 0.0031
614 PERITONITIS 49 0.0030
615 GLOMERULAR FILTRATION RATE DECREASED 21 0.0030
616 MYOCARDITIS 18 0.0030
617 SHOCK 48 0.0030
618 THROMBOSIS 176 0.0030
619 MULTI-ORGAN FAILURE 52 0.0030
620 INFLAMMATION 92 0.0030
621 HYDROCEPHALUS 12 0.0030
622 APPENDICITIS 18 0.0030
623 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0030
624 URINARY TRACT INFECTION 338 0.0030
625 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0030
626 ASPIRATION 22 0.0029
627 MENINGITIS 14 0.0029
628 MITRAL VALVE INCOMPETENCE 25 0.0029
629 BLOOD CALCIUM DECREASED 24 0.0029
630 HYPERTENSION 422 0.0029
631 DYSPNOEA 1148 0.0029
632 DIARRHOEA HAEMORRHAGIC 19 0.0029
633 INTENTIONAL PRODUCT USE ISSUE 133 0.0029
634 DYSURIA 77 0.0028
635 COAGULOPATHY 36 0.0028
636 NEURALGIA 45 0.0028
637 PULMONARY CONGESTION 26 0.0028
638 INFUSION RELATED REACTION 103 0.0028
639 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0027
640 ARTERIAL OCCLUSIVE DISEASE 17 0.0027
641 WOUND INFECTION 17 0.0027
642 HIP ARTHROPLASTY 24 0.0027
643 NERVOUS SYSTEM DISORDER 69 0.0027
644 RESPIRATORY RATE INCREASED 17 0.0027
645 CARDIAC ARREST 170 0.0027
646 MOUTH ULCERATION 38 0.0027
647 VENTRICULAR FIBRILLATION 23 0.0027
648 PROCTALGIA 12 0.0027
649 RECTAL HAEMORRHAGE 86 0.0027
650 HAEMODIALYSIS 21 0.0026
651 DRUG ERUPTION 31 0.0026
652 BODY TEMPERATURE DECREASED 19 0.0026
653 HEMIPARESIS 35 0.0026
654 NO THERAPEUTIC RESPONSE 32 0.0026
655 PANCREATITIS ACUTE 41 0.0026
656 SKIN HYPERPIGMENTATION 17 0.0026
657 FATIGUE 1332 0.0026
658 METABOLIC ACIDOSIS 54 0.0026
659 OXYGEN SATURATION DECREASED 87 0.0026
660 OSTEOMYELITIS 36 0.0026
661 CONFUSIONAL STATE 302 0.0025
662 SHOCK HAEMORRHAGIC 14 0.0025
663 HAEMORRHAGE INTRACRANIAL 31 0.0025
664 CYANOSIS 30 0.0025
665 PALLOR 46 0.0025
666 FLUID OVERLOAD 37 0.0025
667 BREAST PAIN 21 0.0025
668 PHARYNGITIS 23 0.0025
669 GRAND MAL CONVULSION 23 0.0025
670 ILL-DEFINED DISORDER 69 0.0025
671 LETHARGY 107 0.0025
672 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0025
673 TRANSIENT ISCHAEMIC ATTACK 65 0.0025
674 HEPATOMEGALY 19 0.0024
675 ANAPHYLACTIC SHOCK 41 0.0024
676 CARDIOGENIC SHOCK 22 0.0024
677 BLOOD COUNT ABNORMAL 41 0.0024
678 STAPHYLOCOCCAL INFECTION 61 0.0024
679 SPINAL OSTEOARTHRITIS 16 0.0024
680 NODULE 21 0.0024
681 GINGIVAL BLEEDING 22 0.0024
682 WEIGHT FLUCTUATION 14 0.0024
683 HOSPICE CARE 12 0.0024
684 TOXIC EPIDERMAL NECROLYSIS 25 0.0024
685 HEPATOCELLULAR CARCINOMA 13 0.0024
686 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 75 0.0023
687 RHABDOMYOLYSIS 72 0.0023
688 DIALYSIS 26 0.0023
689 END STAGE RENAL DISEASE 35 0.0023
690 BONE PAIN 97 0.0023
691 DEATH 1316 0.0023
692 FACE OEDEMA 29 0.0023
693 BONE DISORDER 33 0.0023
694 NIGHT SWEATS 48 0.0022
695 UNRESPONSIVE TO STIMULI 42 0.0022
696 PRODUCTIVE COUGH 66 0.0022
697 STATUS EPILEPTICUS 18 0.0022
698 PERICARDITIS 16 0.0022
699 DRUG EFFECT INCOMPLETE 81 0.0022
700 ERYTHEMA 326 0.0022
701 ALTERED STATE OF CONSCIOUSNESS 31 0.0022
702 ULCER 25 0.0022
703 PELVIC PAIN 30 0.0022
704 BLADDER DISORDER 16 0.0022
705 HYPOTONIA 17 0.0022
706 EMPHYSEMA 17 0.0022
707 DYSGEUSIA 117 0.0022
708 ABDOMINAL PAIN LOWER 41 0.0022
709 TOOTH INFECTION 19 0.0022
710 SKIN DISORDER 45 0.0021
711 PULMONARY HYPERTENSION 34 0.0021
712 HAEMATOMA 43 0.0021
713 CHEST PAIN 296 0.0021
714 GASTROINTESTINAL DISORDER 106 0.0021
715 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0021
716 ORAL PAIN 34 0.0021
717 GASTROINTESTINAL PAIN 15 0.0021
718 CYTOMEGALOVIRUS INFECTION 24 0.0021
719 FISTULA 15 0.0021
720 THERAPEUTIC RESPONSE DECREASED 85 0.0021
721 MUSCULAR WEAKNESS 170 0.0021
722 COUGH 375 0.0021
723 UPPER RESPIRATORY TRACT INFECTION 65 0.0020
724 EOSINOPHILIA 24 0.0020
725 RASH ERYTHEMATOUS 59 0.0020
726 HYPERAESTHESIA 13 0.0020
727 CARDIO-RESPIRATORY ARREST 67 0.0020
728 DYSARTHRIA 57 0.0020
729 HYPOTHERMIA 15 0.0020
730 RASH 572 0.0020
731 IMMUNODEFICIENCY 16 0.0020
732 NEOPLASM MALIGNANT 87 0.0020
733 ATAXIA 18 0.0020
734 WEIGHT DECREASED 383 0.0020
735 GROIN PAIN 13 0.0020
736 HIATUS HERNIA 20 0.0020
737 CARDIAC MURMUR 14 0.0020
738 HEPATITIS C 21 0.0020
739 OSTEONECROSIS 53 0.0019
740 NEPHROPATHY 14 0.0019
741 INCONTINENCE 15 0.0019
742 CYSTITIS 46 0.0019
743 BRONCHOSPASM 21 0.0019
744 ALOPECIA 275 0.0019
745 DYSPHAGIA 125 0.0019
746 LEUKAEMIA 12 0.0019
747 PARAESTHESIA 216 0.0019
748 DERMATITIS ALLERGIC 15 0.0019
749 LOWER RESPIRATORY TRACT INFECTION 52 0.0019
750 HAEMATOCHEZIA 64 0.0019
751 POST PROCEDURAL COMPLICATION 27 0.0019
752 HAEMORRHAGE 133 0.0018
753 DEAFNESS 33 0.0018
754 DELIRIUM 43 0.0018
755 DIVERTICULITIS 35 0.0018
756 ABDOMINAL DISTENSION 130 0.0018
757 SKIN LESION 33 0.0018
758 BLOOD POTASSIUM DECREASED 39 0.0018
759 TACHYPNOEA 16 0.0018
760 FULL BLOOD COUNT DECREASED 22 0.0018
761 BREAST CANCER 127 0.0018
762 HEPATIC CIRRHOSIS 22 0.0018
763 TINNITUS 58 0.0018
764 TOOTH EXTRACTION 16 0.0017
765 CARDIAC FAILURE CONGESTIVE 121 0.0017
766 BLINDNESS 47 0.0017
767 PARALYSIS 18 0.0017
768 CHROMATURIA 29 0.0017
769 DRUG INTERACTION 196 0.0017
770 HYPERTHYROIDISM 16 0.0017
771 TOOTH ABSCESS 13 0.0017
772 ORAL HERPES 20 0.0017
773 VENTRICULAR TACHYCARDIA 20 0.0017
774 RESPIRATORY DISORDER 35 0.0016
775 CEREBRAL HAEMORRHAGE 44 0.0016
776 MICTURITION URGENCY 13 0.0016
777 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0016
778 THROAT TIGHTNESS 31 0.0016
779 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0016
780 CEREBROVASCULAR ACCIDENT 209 0.0016
781 TUBERCULOSIS 14 0.0016
782 IMPAIRED HEALING 34 0.0016
783 CONDITION AGGRAVATED 273 0.0016
784 HYPERSENSITIVITY 198 0.0015
785 HAEMORRHOIDS 22 0.0015
786 LUNG NEOPLASM MALIGNANT 45 0.0015
787 OBESITY 16 0.0015
788 HYPOTHYROIDISM 31 0.0015
789 HEPATIC ENZYME INCREASED 66 0.0015
790 APHASIA 34 0.0015
791 BLOOD POTASSIUM INCREASED 18 0.0015
792 PRODUCT ADMINISTRATION ERROR 13 0.0015
793 PSYCHOTIC DISORDER 33 0.0015
794 HERPES ZOSTER 60 0.0015
795 ADVERSE EVENT 98 0.0015
796 DYSPHONIA 59 0.0015
797 BACK PAIN 244 0.0015
798 DISORIENTATION 46 0.0015
799 WOUND 22 0.0014
800 STEVENS-JOHNSON SYNDROME 25 0.0014
801 EYELID OEDEMA 14 0.0014
802 ABDOMINAL PAIN UPPER 200 0.0014
803 PERIPHERAL COLDNESS 14 0.0014
804 PHOTOPHOBIA 17 0.0014
805 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0014
806 FUNGAL INFECTION 31 0.0013
807 MUSCULOSKELETAL DISORDER 19 0.0013
808 ANGINA PECTORIS 30 0.0013
809 MUSCULOSKELETAL PAIN 60 0.0013
810 BRAIN OEDEMA 12 0.0013
811 EPILEPSY 26 0.0013
812 BRADYCARDIA 51 0.0013
813 MYALGIA 158 0.0013
814 RETCHING 19 0.0013
815 EAR PAIN 17 0.0013
816 DIPLOPIA 23 0.0013
817 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0013
818 LOCAL SWELLING 22 0.0013
819 LOSS OF CONSCIOUSNESS 119 0.0013
820 PAIN IN JAW 27 0.0012
821 HYPOGLYCAEMIA 46 0.0012
822 FAECES DISCOLOURED 20 0.0012
823 COLD SWEAT 16 0.0012
824 LACTIC ACIDOSIS 25 0.0012
825 DISCOMFORT 42 0.0012
826 ARRHYTHMIA 44 0.0012
827 VERTIGO 55 0.0012
828 PRURITUS 276 0.0012
829 RASH PAPULAR 21 0.0012
830 POLLAKIURIA 36 0.0012
831 PANCREATITIS 48 0.0012
832 BLOOD PRESSURE DECREASED 57 0.0012
833 GOUT 15 0.0012
834 HYPERHIDROSIS 113 0.0012
835 HYPOAESTHESIA 128 0.0012
836 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0012
837 BLISTER 43 0.0012
838 DIABETES MELLITUS 67 0.0012
839 SUBDURAL HAEMATOMA 13 0.0012
840 PAIN 460 0.0012
841 CENTRAL NERVOUS SYSTEM LESION 13 0.0011
842 PRODUCT PRESCRIBING ERROR 12 0.0011
843 FEELING HOT 49 0.0011
844 CONVULSION 65 0.0011
845 SPINAL FRACTURE 15 0.0011
846 CORONARY ARTERY DISEASE 30 0.0011
847 PAIN IN EXTREMITY 242 0.0011
848 ARTHROPATHY 41 0.0011
849 DYSPEPSIA 75 0.0011
850 URINARY INCONTINENCE 24 0.0011
851 VISUAL ACUITY REDUCED 32 0.0011
852 RENAL DISORDER 36 0.0011
853 PRODUCT USE ISSUE 128 0.0011
854 EATING DISORDER 16 0.0011
855 RASH PRURITIC 38 0.0011
856 CORONARY ARTERY OCCLUSION 12 0.0010
857 COORDINATION ABNORMAL 12 0.0010
858 MALAISE 335 0.0010
859 LOCALISED INFECTION 17 0.0010
860 BLOOD PRESSURE INCREASED 107 0.0010
861 DIZZINESS 348 0.0010
862 RENAL INJURY 26 0.0010
863 CHOLELITHIASIS 24 0.0010
864 INTERVERTEBRAL DISC PROTRUSION 16 0.0010
865 FLUSHING 77 0.0010
866 CARDIOVASCULAR DISORDER 21 0.0010
867 SKIN EXFOLIATION 52 0.0010
868 CHEST DISCOMFORT 66 0.0009
869 COMA 33 0.0009
870 RESTLESSNESS 25 0.0009
871 DIABETIC KETOACIDOSIS 16 0.0009
872 DRY EYE 23 0.0009
873 OROPHARYNGEAL PAIN 56 0.0009
874 VIRAL INFECTION 20 0.0009
875 VISION BLURRED 86 0.0009
876 DRUG INEFFECTIVE 803 0.0009
877 RIB FRACTURE 13 0.0009
878 TREATMENT NONCOMPLIANCE 30 0.0009
879 NECK PAIN 35 0.0009
880 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0009
881 BRONCHITIS 49 0.0009
882 LIMB DISCOMFORT 18 0.0009
883 PERIPHERAL SWELLING 82 0.0009
884 MYOCARDIAL INFARCTION 128 0.0009
885 TOOTH LOSS 13 0.0009
886 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0009
887 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0009
888 ACCIDENTAL OVERDOSE 21 0.0008
889 COVID-19 28 0.0008
890 PRURITUS GENERALISED 18 0.0008
891 RHINORRHOEA 34 0.0008
892 OSTEOARTHRITIS 24 0.0008
893 CARDIAC DISORDER 57 0.0008
894 COGNITIVE DISORDER 26 0.0008
895 VISUAL IMPAIRMENT 64 0.0008
896 SINUSITIS 55 0.0008
897 VAGINAL HAEMORRHAGE 27 0.0008
898 OCULAR HYPERAEMIA 22 0.0008
899 INFLUENZA 54 0.0008
900 GAIT DISTURBANCE 106 0.0008
901 SEIZURE 53 0.0008
902 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0008
903 NEPHROLITHIASIS 23 0.0008
904 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0008
905 SKIN DISCOLOURATION 25 0.0008
906 FALL 176 0.0007
907 RASH MACULAR 17 0.0007
908 BLADDER CANCER 30 0.0007
909 GASTRIC DISORDER 22 0.0007
910 AGITATION 42 0.0007
911 ABASIA 18 0.0007
912 HYPOACUSIS 19 0.0007
913 HEART RATE INCREASED 50 0.0007
914 ELECTROCARDIOGRAM QT PROLONGED 18 0.0007
915 SOMNOLENCE 103 0.0007
916 OSTEOPOROSIS 21 0.0007
917 FLATULENCE 28 0.0007
918 WHEEZING 26 0.0007
919 SWELLING 43 0.0007
920 FLUID RETENTION 26 0.0007
921 DEPRESSION 122 0.0007
922 HEADACHE 305 0.0007
923 DRY SKIN 58 0.0007
924 FEMUR FRACTURE 17 0.0007
925 ANGIOEDEMA 21 0.0007
926 ECZEMA 12 0.0007
927 HIP FRACTURE 15 0.0007
928 URTICARIA 75 0.0007
929 ARTHRALGIA 176 0.0007
930 TREMOR 80 0.0006
931 ARTHRITIS 34 0.0006
932 RESPIRATORY ARREST 15 0.0006
933 HALLUCINATION 32 0.0006
934 CATARACT 24 0.0006
935 CHRONIC KIDNEY DISEASE 39 0.0006
936 DYSSTASIA 13 0.0006
937 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
938 DRUG HYPERSENSITIVITY 87 0.0006
939 SPEECH DISORDER 23 0.0006
940 SWOLLEN TONGUE 14 0.0006
941 HEAD INJURY 13 0.0006
942 RASH GENERALISED 15 0.0006
943 INFLUENZA LIKE ILLNESS 37 0.0006
944 PALPITATIONS 48 0.0006
945 WEIGHT INCREASED 86 0.0006
946 HOT FLUSH 26 0.0005
947 INSOMNIA 106 0.0005
948 ABDOMINAL DISCOMFORT 59 0.0005
949 BLOOD GLUCOSE INCREASED 77 0.0005
950 ADVERSE DRUG REACTION 27 0.0005
951 ANXIETY 105 0.0005
952 EMOTIONAL DISORDER 12 0.0005
953 DRY MOUTH 26 0.0005
954 MOBILITY DECREASED 22 0.0005
955 AMNESIA 23 0.0005
956 BALANCE DISORDER 29 0.0005
957 SWELLING FACE 21 0.0004
958 MEDICATION ERROR 18 0.0004
959 DYSKINESIA 13 0.0004
960 BLOOD CHOLESTEROL INCREASED 14 0.0004
961 EYE PAIN 14 0.0004
962 SUICIDE ATTEMPT 18 0.0004
963 EXPOSURE DURING PREGNANCY 16 0.0004
964 DEPRESSED MOOD 14 0.0004
965 MUSCLE SPASMS 50 0.0004
966 MIGRAINE 23 0.0004
967 UNEVALUABLE EVENT 21 0.0004
968 CONTUSION 24 0.0004
969 HOSPITALISATION 31 0.0004
970 BURNING SENSATION 18 0.0004
971 STRESS 16 0.0003
972 INCORRECT DOSE ADMINISTERED 37 0.0003
973 BLOOD GLUCOSE DECREASED 12 0.0003
974 INJURY 18 0.0003
975 SLEEP DISORDER 13 0.0003
976 UNDERDOSE 15 0.0003
977 MUSCULOSKELETAL STIFFNESS 15 0.0003
978 NASOPHARYNGITIS 30 0.0003
979 PROSTATE CANCER 13 0.0003
980 JOINT SWELLING 19 0.0002
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
982 SKIN BURNING SENSATION 13 0.0002
983 EMOTIONAL DISTRESS 15 0.0002
984 FEELING ABNORMAL 41 0.0002
985 OVERDOSE 32 0.0002
986 DRUG EFFECT DECREASED 12 0.0002
987 ACNE 13 0.0002
988 MEMORY IMPAIRMENT 21 0.0002
989 ASTHMA 13 0.0002
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0002
991 NO ADVERSE EVENT 13 0.0001
992 DRUG DOSE OMISSION 18 0.0001
993 PRODUCT QUALITY ISSUE 12 0.0001
994 INJECTION SITE PAIN 17 0.0001